News and Events
New AI tool classifies brain tumors using images of tumor slides
A new artificial intelligence model has been found to be highly effective at identifying brain tumor subtypes — with 95% accuracy — simply by analyzing a standard pathology image of the tumor tissue.
Read More
New research identifies a protein essential to maintaining chromosomal stability
Researchers discovered how overproduction of a protein called CENP-A can lead to chromosomal abnormalities, which are found in many types of cancer.
Read More
New database of sarcoma cell line data will drive rare cancer research
CCR researchers have developed the largest publicly accessible sarcoma cell line database called Sarcoma CellMinerCDB. The tool merges previously available and new sarcoma cell line data that can be used to identify new therapeutic targets for these cancers.
Read More
Clinical trial researching combination therapy for solid tumors
A trial led by Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, is researching white blood cell gene therapy and vaccine therapy for certain metastatic cancers.
Read More
Three CCR researchers elected to the National Academy of Sciences
Steven A. Rosenberg, M.D, Ph.D., Chief of the Surgery Branch, Giorgio Trinchieri, M.D., Chief of the Laboratory of Integrative Cancer Immunology, and Sandra L. Wolin, M.D., Ph.D., Chief of the RNA Biology Laboratory, were elected as 2024 members of the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research. The Academy is committed to furthering science in America, and its members are outstanding contributors to the international scientific community.
Read More
Clinical trial researching detection methods for multiple myeloma
A trial led by Elizabeth M. Hill, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is studying a radiotracer that may be a useful detection method for multiple myeloma.
Read More
Aligned Blog: Celebrating National Minority Health Month: Improving Health Through Culture, Communities and Connections
To celebrate National Minority Health Month, Brenda Adjei, Ed.D., M.P.A., Associate Director of CCR's Office of Healthcare Delivery and Equity Research, expands on this year's theme, "Be the Source for Better Health," and highlights some CCR researchers striving to make cancer care more equitable.
Read More
Jung-Min Lee elected to the American Society for Clinical Investigation
Jung-Min Lee, M.D., Senior Investigator in the Women’s Malignancies Branch, was elected to the American Society for Clinical Investigation. The organization seeks to support scientific efforts, educational needs and clinical aspirations of physician-scientists to improve the health of all people. Lee was selected for her merit as an internationally recognized expert in ovarian cancer and for being a highly respected clinician and physician-scientist.
Read More
CCR researchers receive a range of HHS awards
Three CCR researchers received prestigious awards from the Department of Health and Human Services. They are being recognized for their excellence, dedication and achievements in their respective research fields.
Read More
CCR researchers elected to the Association of American Physicians
Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, and Yves Pommier, M.D., Ph.D., Chief of the Developmental Therapeutics Branch, were elected as 2024 members of the Association of American Physicians. The organization seeks to inspire physician-led research across all fields of science and medicine to improve patient health care and the health of Americans.
Read More
Study sheds light on diversity of study participants at CCR
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes representation based on sex, age and ethnicity in clinical trials done at CCR.
Read More